First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment
Abstract Immunotherapies based on antibody fragments have been developed and applied to human diseases, describing novel antibody formats. The vNAR domains have a potential therapeutic use related to their unique properties. This work used a non-immunized Heterodontus francisci shark library to obta...
Main Authors: | Mirna Burciaga-Flores, Ana Laura Márquez-Aguirre, Salvador Dueñas, Jahaziel Gasperin-Bulbarela, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-30623-x |
Similar Items
-
Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization
by: Tanya A. Camacho-Villegas, et al.
Published: (2018-03-01) -
Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3.
by: Olivia Cabanillas-Bernal, et al.
Published: (2019-01-01) -
Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
by: Blanca J. Valdovino-Navarro, et al.
Published: (2022-10-01) -
vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target
by: Alejandro Manzanares-Guzmán, et al.
Published: (2024-03-01) -
Preparation of pH-sensitive nanogels bioconjugated with shark antibodies (VNAR) for targeted drug delivery with potential applications in colon cancer therapies.
by: Lizbeth A Manzanares-Guevara, et al.
Published: (2024-01-01)